These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 26524334)

  • 61. Kaposi sarcoma-associated herpesvirus (KSHV): molecular biology and oncogenesis.
    Wen KW; Damania B
    Cancer Lett; 2010 Mar; 289(2):140-50. PubMed ID: 19651473
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Linking the Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) to human malignancies.
    Kalt I; Masa SR; Sarid R
    Methods Mol Biol; 2009; 471():387-407. PubMed ID: 19109790
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Productive lytic replication of a recombinant Kaposi's sarcoma-associated herpesvirus in efficient primary infection of primary human endothelial cells.
    Gao SJ; Deng JH; Zhou FC
    J Virol; 2003 Sep; 77(18):9738-49. PubMed ID: 12941882
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Oncolytic Reactivation of KSHV as a Therapeutic Approach for Primary Effusion Lymphoma.
    Zhou F; Shimoda M; Olney L; Lyu Y; Tran K; Jiang G; Nakano K; Davis RR; Tepper CG; Maverakis E; Campbell M; Li Y; Dandekar S; Izumiya Y
    Mol Cancer Ther; 2017 Nov; 16(11):2627-2638. PubMed ID: 28847988
    [TBL] [Abstract][Full Text] [Related]  

  • 65. An endothelial cell line infected by Kaposi's sarcoma-associated herpes virus (KSHV) allows the investigation of Kaposi's sarcoma and the validation of novel viral inhibitors in vitro and in vivo.
    Dubich T; Lieske A; Santag S; Beauclair G; Rückert J; Herrmann J; Gorges J; Büsche G; Kazmaier U; Hauser H; Stadler M; Schulz TF; Wirth D
    J Mol Med (Berl); 2019 Mar; 97(3):311-324. PubMed ID: 30610257
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The Zebrafish Xenograft Platform-A Novel Tool for Modeling KSHV-Associated Diseases.
    Pringle ES; Wertman J; Melong N; Coombs AJ; Young AL; O'Leary D; Veinotte C; Robinson CA; Ha MN; Dellaire G; Druley TE; McCormick C; Berman JN
    Viruses; 2019 Dec; 12(1):. PubMed ID: 31861850
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Human herpesvirus 8: biology and role in the pathogenesis of Kaposi's sarcoma and other AIDS-related malignancies.
    Viejo-Borbolla A; Ottinger M; Schulz TF
    Curr HIV/AIDS Rep; 2004 Apr; 1(1):5-11. PubMed ID: 16091217
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Human herpesvirus 8 (HHV8). II. Pathogenic role and sensitivity to antiviral drugs].
    Boulanger E
    Ann Biol Clin (Paris); 1999; 57(1):19-28. PubMed ID: 9920963
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Delta-9 tetrahydrocannabinol (THC) inhibits lytic replication of gamma oncogenic herpesviruses in vitro.
    Medveczky MM; Sherwood TA; Klein TW; Friedman H; Medveczky PG
    BMC Med; 2004 Sep; 2():34. PubMed ID: 15369590
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Human immunodeficiency virus replication in a primary effusion lymphoma cell line stimulates lytic-phase replication of Kaposi's sarcoma-associated herpesvirus.
    Varthakavi V; Browning PJ; Spearman P
    J Virol; 1999 Dec; 73(12):10329-38. PubMed ID: 10559351
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Treatment for Kaposi sarcoma herpesvirus: great challenges with promising accomplishments.
    Arav-Boger R
    Virus Genes; 2009 Apr; 38(2):195-203. PubMed ID: 19139983
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Targeting the PI3K and MAPK pathways to treat Kaposi's-sarcoma-associated herpes virus infection and pathogenesis.
    Lambert PJ; Shahrier AZ; Whitman AG; Dyson OF; Reber AJ; McCubrey JA; Akula SM
    Expert Opin Ther Targets; 2007 May; 11(5):589-99. PubMed ID: 17465719
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cell membrane-bound Kaposi's sarcoma-associated herpesvirus-encoded glycoprotein B promotes virus latency by regulating expression of cellular Egr-1.
    Dyson OF; Traylen CM; Akula SM
    J Biol Chem; 2010 Nov; 285(48):37491-502. PubMed ID: 20864524
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Potent antiviral activity of north-methanocarbathymidine against Kaposi's sarcoma-associated herpesvirus.
    Zhu W; Burnette A; Dorjsuren D; Roberts PE; Huleihel M; Shoemaker RH; Marquez VE; Agbaria R; Sei S
    Antimicrob Agents Chemother; 2005 Dec; 49(12):4965-73. PubMed ID: 16304159
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Cytokine-Targeted Therapeutics for KSHV-Associated Disease.
    Alomari N; Totonchy J
    Viruses; 2020 Sep; 12(10):. PubMed ID: 32998419
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Activation of cellular metabolism during latent Kaposi's Sarcoma herpesvirus infection.
    Lagunoff M
    Curr Opin Virol; 2016 Aug; 19():45-9. PubMed ID: 27434732
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Signaling cascades triggered by bacterial metabolic end products during reactivation of Kaposi's sarcoma-associated herpesvirus.
    Morris TL; Arnold RR; Webster-Cyriaque J
    J Virol; 2007 Jun; 81(11):6032-42. PubMed ID: 17376930
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Selective peptide inhibitors of antiapoptotic cellular and viral Bcl-2 proteins lead to cytochrome c release during latent Kaposi's sarcoma-associated herpesvirus infection.
    Burrer CM; Foight GW; Keating AE; Chan GC
    Virus Res; 2016 Jan; 211():86-8. PubMed ID: 26456186
    [TBL] [Abstract][Full Text] [Related]  

  • 79. KSHV: pathways to tumorigenesis and persistent infection.
    Giffin L; Damania B
    Adv Virus Res; 2014; 88():111-59. PubMed ID: 24373311
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Role of SUMOylation in Human Oncogenic Herpesvirus Infection.
    Zhang Y; Wang Y; Zhu C; Robertson ES; Cai Q
    Virus Res; 2020 Jul; 283():197962. PubMed ID: 32283130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.